These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 7831438)

  • 21. The neuropathology of schizophrenia.
    Bachus SE; Kleinman JE
    J Clin Psychiatry; 1996; 57 Suppl 11():72-83. PubMed ID: 8941174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride.
    Kessler RM; Whetsell WO; Ansari MS; Votaw JR; de Paulis T; Clanton JA; Schmidt DE; Mason NS; Manning RG
    Brain Res; 1993 Apr; 609(1-2):237-43. PubMed ID: 8099521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anatomy of co-morbid neuropsychiatric disorders based on cortico-limbic synaptic interactions.
    Totterdell S
    Neurotox Res; 2006 Oct; 10(2):65-85. PubMed ID: 17062369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications.
    Hoebel BG; Hernandez L; Schwartz DH; Mark GP; Hunter GA
    Ann N Y Acad Sci; 1989; 575():171-91; discussion 192-3. PubMed ID: 2699187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortico-thalamic hypo- and hyperconnectivity extend consistently to basal ganglia in schizophrenia.
    Avram M; Brandl F; Bäuml J; Sorg C
    Neuropsychopharmacology; 2018 Oct; 43(11):2239-2248. PubMed ID: 29899404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
    Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease.
    Deutch AY
    J Neural Transm Gen Sect; 1993; 91(2-3):197-221. PubMed ID: 8099797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathology, phenomenology and the dopamine hypothesis of schizophrenia.
    McKenna PJ
    Br J Psychiatry; 1987 Sep; 151():288-301. PubMed ID: 3322465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between excitatory amino acids and dopamine systems in the forebrain: implications for schizophrenia and Parkinson's disease.
    Iversen SD
    Behav Pharmacol; 1995 Aug; 6(5 And 6):478-491. PubMed ID: 11224356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.
    Nikolaus S; Antke C; Müller HW
    Behav Brain Res; 2009 Dec; 204(1):32-66. PubMed ID: 19523495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gating of information flow within the limbic system and the pathophysiology of schizophrenia.
    Grace AA
    Brain Res Brain Res Rev; 2000 Mar; 31(2-3):330-41. PubMed ID: 10719160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional anatomy of thalamus and basal ganglia.
    Herrero MT; Barcia C; Navarro JM
    Childs Nerv Syst; 2002 Aug; 18(8):386-404. PubMed ID: 12192499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efferent connections of the ventral pallidum: evidence of a dual striato pallidofugal pathway.
    Haber SN; Groenewegen HJ; Grove EA; Nauta WJ
    J Comp Neurol; 1985 May; 235(3):322-35. PubMed ID: 3998213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lateralized interdependence between limbicotemporal and ventrostriatal dopaminergic transmission.
    Louilot A; Le Moal M
    Neuroscience; 1994 Apr; 59(3):495-500. PubMed ID: 7911983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NE/DA interactions in prefrontal cortex and their possible roles as neuromodulators in schizophrenia.
    Tassin JP
    J Neural Transm Suppl; 1992; 36():135-62. PubMed ID: 1356142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters.
    O'Donnell P; Grace AA
    Schizophr Bull; 1998; 24(2):267-83. PubMed ID: 9613625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The organization of the projection from the cerebral cortex to the striatum in the rat.
    McGeorge AJ; Faull RL
    Neuroscience; 1989; 29(3):503-37. PubMed ID: 2472578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organization of subcortical pathways for sensory projections to the limbic cortex. I. Subcortical projections to the medial limbic cortex in the rat.
    Thompson SM; Robertson RT
    J Comp Neurol; 1987 Nov; 265(2):175-88. PubMed ID: 3320108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoamines and schizophrenia.
    Sedvall G
    Acta Psychiatr Scand Suppl; 1990; 358():7-13. PubMed ID: 1978495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.